Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
text
Tags
abbvie
aimmune therapeutics
akcea therapeutics
akebia therapeutics
alex pinto
amarin pharma
amarna therapeutics
amylyx
amyotrophic lateral sclerosis (als)
anemia
antibody drug
biofourmis
biotech
boston blog main
boston pharmaceuticals
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
casdin capital
chronic kidney disease
clene nanomedicine
clinical trials
corvex management
covid-19
cystic fibrosis
detroit blog main
detroit top stories
digital therapeutics
dov goldstein
ed rebar
europe blog main
europe top stories
fda
gene therapy
gilead sciences
glaxosmithkline
graybug vision
hibiskus biopharma
hikma pharmaceuticals
What
people
3
×
pharma
3
×
abbvie’s
ahead
analysed
aren’t
assume
benefits
big
billion
bio
biofourmis
broken
bucks
cancer
celebrate
chance
circles
companies
corner
current
day
days
design
designed
dlc
drugs
effective
evil
exaggerate
favour
flawed
flu
forward
holiday
hopelessly
immunizations
investment
isn't
known
Language
unset
Current search:
pharma
×
people
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@WIRED
6 years ago
It’s well-known in medical circles that flu vaccines aren’t nearly as protective as most people assume. But since these current vaccines are still ...
@eurogamer.net
7 years ago
Even with the Marketing and Malpractice DLC, Big Pharma just isn't evil enough
